Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes. - Lyu, Young Sang; Lee, Hansol; Kim, Kyung-Soo; Hong, Sangmo; Park, Cheol-Young (Cardiovascular Diabetology, 2025)